ERG-mediated activation of miR-200b/200a/429 expression interferes with prostate cancer proliferation and invasiveness, an effect that implicates the ERG-miR-200 interaction in the indolent behavior of prostate cancer in the majority of patients [82]. This evidence concerns the gene ERG and prostate carcinoma.